Payments to Acquire Property, Plant, and Equipment of Aquestive Therapeutics, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Aquestive Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Aquestive Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $135,000, a 366% increase year-over-year.
  • Aquestive Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $562,000, a 253% increase from 2024.
  • Aquestive Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $159,000, a 84% decline from 2023.
  • Aquestive Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $995,000, a 2.8% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Aquestive Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $562,000 +$403,000 +253% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 $159,000 -$836,000 -84% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 $995,000 -$29,000 -2.8% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2025 2024 FY
2022 $1,024,000 +$111,000 +12% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 $913,000 +$396,000 +77% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $517,000 -$146,000 -22% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
2019 $663,000 -$1,161,000 -64% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
2018 $1,824,000 -$244,000 -12% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2020 2019 FY
2017 $2,068,000 01 Jan 2017 31 Dec 2017 10-K 14 Mar 2019 2018 FY

Aquestive Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $135,000 +$106,000 +366% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $29,000 +$27,000 +1350% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q1 2023 $2,000 -$102,000 -98% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $104,000 +$1,000 +0.97% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q1 2021 $103,000 -$28,000 -21% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $131,000 -$245,000 -65% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $376,000 +$117,000 +45% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q1
Q1 2018 $259,000 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.